Showing results (181-190 of 301) with videos related to
Sort By:
Pageof 31
Arthritis Research & Therapy|November 6, 2010
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosusCapucine Daridon, Daniela Blassfeld, Karin Reiter, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2005
Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapySerengulam V Govindan, Gary L Griffiths, Rhona Stein, et al.Molecular Cancer Therapeutics|October 29, 2017
Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130)Robert M Sharkey, Serengulam V Govindan, Thomas M Cardillo, et al.Journal of Experimental & Clinical Cancer Research : CR|October 12, 2014
CD74 interferes with the expression of fas receptor on the surface of lymphoma cellsZuzana Berkova, Shu Wang, Xue Ao, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
A novel facile method of labeling octreotide with (18)F-fluorinePeter Laverman, William J McBride, Robert M Sharkey, et al.Plos One|July 31, 2012
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitroChien-Hsing Chang, Jorma Hinkula, Meiyu Loo, et al.Radiology|January 30, 2008
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse modelRobert M Sharkey, Habibe Karacay, Shankar Vallabhajosula, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patientsJeffry A Siegel, Dion Yeldell, David M Goldenberg, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2011
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclideEric Frampas, Catherine Maurel, Patricia Remaud-Le Saëc, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphomaRobert M Sharkey, Habibe Karacay, Christine R Johnson, et al.Pageof 31